Verónica Pulito-Cueto, María Sebastián Mora-Gil, Diego Ferrer-Pargada, Sara Remuzgo-Martínez, Fernanda Genre, Leticia Lera-Gómez, Pilar Alonso-Lecue, Joao Carlos Batista-Liz, Sandra Tello-Mena, Beatriz Abascal-Bolado, Sheila Izquierdo, Juan José Ruiz-Cubillán, Carlos Armiñanzas-Castillo, Ricardo Blanco, Miguel A González-Gay, Raquel López-Mejías, José M Cifrián
The most critical forms of coronavirus disease 2019 (COVID-19) are associated with excessive activation of the inflammasome. Despite the COVID-19 impact on public health, we still do not fully understand the mechanisms by which the inflammatory response influences disease prognosis. Accordingly, we aimed to elucidate the role of polymorphisms in the key genes of the formation and signaling of the inflammasome as biomarkers of COVID-19 severity. For this purpose, a large and well-defined cohort of 377 COVID-19 patients with mild (n = 72), moderate (n = 84), severe (n = 100), and critical (n = 121) infections were included...
March 27, 2024: International Journal of Molecular Sciences